X4 Pharmaceuticals, Inc Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
X4 Pharmaceuticals, Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • X4 Pharmaceuticals, Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $4.47M, a 26.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.47M -$1.58M -26.1% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $4.87M -$1.58M -24.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.26M -$1.58M -23.1% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.65M -$1.58M -21.8% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $6.05M -$1.55M -20.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $6.45M -$1.52M -19.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $6.84M -$1.5M -18% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $7.23M -$1.48M -17% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $7.61M -$1.47M -16.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $7.98M -$1.45M -15.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $8.34M -$1.44M -14.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $8.71M +$750K +9.42% Dec 31, 2021 10-K 2023-03-21
Q3 2021 $9.07M +$849K +10.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $9.43M +$7.79M +474% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $9.79M +$7.99M +443% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $7.96M +$6M +306% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $8.22M +$6.11M +290% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.64M -$543K -24.8% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $1.8M -$902K -33.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.96M Dec 31, 2019 10-K 2021-03-19
Q3 2019 $2.11M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $2.19M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $2.71M Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.